Dynamic Audience Activation Puts the “Best” in Next-Best Action
Despite life sciences manufacturers’ considerable planning and investment in HCP engagement programs, too often their message falls short of reaching their target audience....
OptimizeRx Blogs
Enhancing Pharma Marketing ROI with DAAP's Patient Discovery Module
In today’s complex healthcare landscape, keeping up with the latest therapies and treatments can be an overwhelming task for many healthcare professionals (HCPs) particularly...
How Technology Improves the Oncology HCP Experience and Engagement
I recently had the chance to participate in a panel session at the Pharma CX Oncology Summit. Our topic was the oncologist customer experience – specifically how technology...
Maximizing Brand Impact: Four Year-End Strategies for Pharma Marketers
Insights on Omnichannel, AI and Next-Best Action in HCP Engagement
The phrases “omnichannel,” “artificial intelligence” and “next-best action” have become ubiquitous in conversations around how to overcome the challenges of reaching HCPs...
PLD Is Not Enough: Next-Best-Action HCP Engagement Needs the Patient
It’s Time to End Multi-Trigger Targeting for EHR-based HCP Engagement
In life science brands’ quest for highly targeted, clinically-relevant HCP communications, EHR “trigger” data is an increasingly popular choice. Its benefits include accuracy...
Realizing Point-of-Care Opportunities: eBook Insights from EHR Experts
Navigating the EHR Landscape: Market Challenges and Point-of-Care Solution
Life science brand’s need for effective HCP engagement solutions at the point of care (POC) is...
How Integrated Is Your Omnichannel Strategy? Here’s a Quick Guide
Omnichannel programs are at the forefront of today’s HCP engagement strategies – and for good reason. In a March 2023 survey, OptimizeRx found that physicians were actively...
Insights from MedDev: Omnichannel Marketing Solutions for Medtech Brands
Bridging the Health Literacy Gap: Improve HCP and Patient Conversations
Planning for Pharma LOE? The Digital Point-of-Care Makes a Difference
Loss of exclusivity (LOE) is a milestone every novel pharmaceutical product reaches. In anticipation of generic competition and the resulting loss of market share/value,...